Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
3 Months Ended | |
|---|---|---|
Apr. 04, 2026 |
Mar. 29, 2025 |
|
| Shares | ||
| Options outstanding, beginning of period (in shares) | 0.7 | |
| Granted (in shares) | 0.0 | |
| Canceled (in shares) | 0.0 | |
| Exercised (in shares) | (0.2) | |
| Options outstanding, end of period (in shares) | 0.5 | |
| Options exercisable, end of period (in shares) | 0.5 | |
| Weighted-Average Exercise Price | ||
| Options outstanding, beginning of period (in usd per share) | $ 117.87 | |
| Granted (in usd per share) | 0 | |
| Canceled (in usd per share) | 208.66 | |
| Exercised (in usd per share) | 66.48 | |
| Options outstanding, end of period (in usd per share) | 132.81 | |
| Options exercisable, end of period (in dollars per share) | $ 130.22 | |
| Stock compensation expense | $ 8.9 | $ 9.1 |
| Stock Options | ||
| Weighted-Average Exercise Price | ||
| Stock compensation expense | 0.3 | 0.3 |
| Stock Options | Discontinued operations | ||
| Weighted-Average Exercise Price | ||
| Stock compensation expense | $ 0.0 | $ 0.1 |
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost expensed and capitalized for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|